Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.

Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.

A worker in a polyvinyl chloride factory with rapidly progressive diffuse cutaneous scleroderma was treated with the humanized monoclonal antibody (Mab) CAMPATH-1H. Treatment was followed by rapid and substantial improvement in skin score, which was maintained during followup without additional ther...

Bibliografske podrobnosti
Main Authors:	Isaacs, J, Hazleman, B, Chakravarty, K, Grant, J, Hale, G, Waldmann, H
Format:	Journal article
Jezik:	English
Izdano:	1996

Podobne knjige/članki

TREATMENT OF RHEUMATOID-ARTHRITIS WITH HUMANIZED ANTILYMPHOCYTE ANTIBODY CAMPATH-1H
od: Watts, R, et al.
Izdano: (1992)

CAMPATH-1H in inflammatory arthritis.
od: Watts, R, et al.
Izdano: (1993)

Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
od: Isaacs, J, et al.
Izdano: (1995)

Specificity of monoclonal antibody Campath-1.
od: Hale, G, et al.
Izdano: (1988)

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
od: Hale, G, et al.
Izdano: (1994)

Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.
od: Newman, D, et al.
Izdano: (1995)

EFFECTS OF MONOCLONAL-ANTIBODIES OF THE CAMPATH SERIES INVIVO - REQUIREMENTS FOR EFFECTIVE ANTIBODY THERAPY
od: Dyer, M, et al.
Izdano: (1988)

CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura.
od: Lim, S, et al.
Izdano: (1993)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
od: Isaacs, J, et al.
Izdano: (1992)

Humanised monoclonal antibody therapy for rheumatoid arthritis.
od: Isaacs, J, et al.
Izdano: (1992)

Rat monoclonal antibodies for bone marrow transplantation--the CAMPATH series.
od: Waldmann, H, et al.
Izdano: (1985)

Campath-1H therapy in refractory ocular inflammatory disease.
od: Dick, A, et al.
Izdano: (2000)

Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.
od: Hale, G, et al.
Izdano: (1988)

Survival of patients after lymphocytotoxic monoclonal antibody therapy for RA.
od: Isaacs, J, et al.
Izdano: (1998)

Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
od: Naparstek, E, et al.
Izdano: (1999)

RAT MONOCLONAL-ANTIBODIES FOR BONE-MARROW TRANSPLANTATION (BMT) - THE CAMPATH SERIES
od: Waldmann, H, et al.
Izdano: (1985)

Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
od: Isaacs, J, et al.
Izdano: (2004)

REMISSION INDUCTION IN PATIENTS WITH LYMPHOID MALIGNANCIES USING UNCONJUGATED CAMPATH-1 MONOCLONAL-ANTIBODIES
od: Dyer, M, et al.
Izdano: (1990)

Reversal of allograft rejection using the monoclonal antibody, Campath-1G.
od: Friend, P, et al.
Izdano: (1991)

Impact on T-cell depletion and CD34+ cell recovery using humanised CD52 monoclonal antibody (CAMPATH-1H) in BM and PSBC collections; comparison with CAMPATH-1M and CAMPATH-1G.
od: Williams, R, et al.
Izdano: (2000)

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
od: Isaacs, J, et al.
Izdano: (2005)

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
od: Isaacs, J, et al.
Izdano: (2005)

Morbidity not increased in rheumatoid arthritis patient with profound lymphopenia following CD4 monoclonal antibody therapy: comment on the article by Isaacs et al - Reply
od: Isaacs, J, et al.
Izdano: (2002)

Availability of Campath-1 antibodies for bone marrow transplantation.
od: Hale, G, et al.
Izdano: (1995)

Anti-globulin responses to rat and humanized CAMPATH-1 monoclonal antibody used to treat transplant rejection.
od: Rebello, P, et al.
Izdano: (1999)

A personal history of the CAMPATH-1H antibody.
od: Waldmann, H
Izdano: (2002)

Pilot study of CAMPATH-1, a rat monoclonal antibody that fixes human complement, as an immunosuppressant in organ transplantation.
od: Hale, G, et al.
Izdano: (1986)

A therapeutic human IgG4 monoclonal antibody that depletes target cells in humans.
od: Isaacs, J, et al.
Izdano: (1996)

Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation.
od: Hale, G, et al.
Izdano: (1985)

Humanized monoclonal antibody treatment in rheumatoid arthritis.
od: Kyle, V, et al.
Izdano: (1991)

Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection.
od: Hale, G, et al.
Izdano: (1996)

ISOTYPE VARIANTS OF CAMPATH-1 ANTIBODY - REQUIREMENTS FOR EFFECTIVE ANTIBODY ACTION INVIVO
od: Dyer, M, et al.
Izdano: (1989)

CAMPATH-1 antibodies in stem-cell transplantation.
od: Hale, G, et al.
Izdano: (2001)

CAMPATH: from concept to clinic.
od: Waldmann, H, et al.
Izdano: (2005)

Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype.
od: Dyer, M, et al.
Izdano: (1989)

ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES
od: Naparstek, E, et al.
Izdano: (1993)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY FOR SYSTEMIC VASCULITIS
od: Lockwood, C, et al.
Izdano: (1993)

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
od: Lockwood, C, et al.
Izdano: (1993)

Sustained remission of severe resistant autoimmune neutropenia with Campath-1H.
od: Killick, S, et al.
Izdano: (1997)

Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?
od: Hale, G, et al.
Izdano: (2002)